These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32779997)

  • 21. Off-Label Use of Multitarget Stool DNA Testing in Primary Care.
    Agarwal A; Zhang T; Ravindran N; Thuluvath PJ; Maheshwari A
    Am J Gastroenterol; 2021 Apr; 116(4):829-832. PubMed ID: 33982956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery.
    Ebner DW; Burger KN; Broderick B; Mahoney DW; Kellogg TA; Acosta A; Kisiel JB
    Gastro Hep Adv; 2023; 2(7):902-910. PubMed ID: 37876832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.
    Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA
    Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.
    Regge D; Laudi C; Galatola G; Della Monica P; Bonelli L; Angelelli G; Asnaghi R; Barbaro B; Bartolozzi C; Bielen D; Boni L; Borghi C; Bruzzi P; Cassinis MC; Galia M; Gallo TM; Grasso A; Hassan C; Laghi A; Martina MC; Neri E; Senore C; Simonetti G; Venturini S; Gandini G
    JAMA; 2009 Jun; 301(23):2453-61. PubMed ID: 19531785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
    Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
    J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of multitarget stool DNA testing in African American patients.
    Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
    Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal DNA Testing for Colorectal Cancer Screening.
    Carethers JM
    Annu Rev Med; 2020 Jan; 71():59-69. PubMed ID: 31451044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-target stool DNA test: a new high bar for noninvasive screening.
    Ahlquist DA
    Dig Dis Sci; 2015 Mar; 60(3):623-33. PubMed ID: 25492503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening.
    Ahn AB; Kulhari S; Rhee J; Cooper G
    J Am Board Fam Med; 2024; 37(2):328-331. PubMed ID: 38740492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study.
    Cotter TG; Burger KN; Devens ME; Simonson JA; Lowrie KL; Heigh RI; Mahoney DW; Johnson DH; Ahlquist DA; Kisiel JB
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):614-621. PubMed ID: 27999144
    [No Abstract]   [Full Text] [Related]  

  • 32. Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.
    Imperiale TF; Lavin PT; Marti TN; Jakubowski D; Itzkowitz SH; May FP; Limburg PJ; Sweetser S; Daghestani A; Berger BM
    Cancer Prev Res (Phila); 2023 Feb; 16(2):89-97. PubMed ID: 36205504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
    Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
    J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.
    Kisiel JB; Fendrick AM; Ebner DW; Ozbay AB; Vahdat V; Estes C; Limburg PJ
    J Med Econ; 2024; 27(1):746-753. PubMed ID: 38686394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
    Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E
    Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
    Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
    Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing.
    Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC
    J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
    Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
    J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors.
    Ebner DW; Burger KN; Mahoney DW; Broderick BT; Eckmann JD; Devens ME; Lowrie KL; League JB; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Leighton JA; Buttar NS; Rutten LJF; Gurudu SR; Kisiel JB
    Dig Dis Sci; 2023 Sep; 68(9):3721-3731. PubMed ID: 37486445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal neoplasia screening with CT colonography in average-risk asymptomatic subjects: community-based study.
    Edwards JT; Mendelson RM; Fritschi L; Foster NM; Wood C; Murray D; Forbes GM
    Radiology; 2004 Feb; 230(2):459-64. PubMed ID: 14688402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.